Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Super Hi International Holding ADR | HDL | Nov 4, 2024 | 17.01 | +4.55 |
Super League Enterprise | SLE | Nov 4, 2024 | 0.96 | -7.69 |
Super Micro Computer | SMCI | Nov 4, 2024 | 26.03 | -0.08 |
Supercom | SPCB | Nov 4, 2024 | 3.09 | -2.52 |
Superior Group of Companies | SGC | Nov 4, 2024 | 15.16 | +0.93 |
Superior Industries International | SUP | Nov 4, 2024 | 2.63 | -2.95 |
Supernus Pharmaceuticals | SUPN | Nov 4, 2024 | 34.70 | +2.15 |
Surf Air Mobility | SRFM | Nov 4, 2024 | 1.64 | -7.87 |
SurgePays | SURG | Nov 4, 2024 | 1.63 | +1.88 |
Surgery Partners | SGRY | Nov 4, 2024 | 29.22 | +1.63 |
Surmodics | SRDX | Nov 4, 2024 | 37.57 | -0.16 |
Suro Capital | SSSS | Nov 4, 2024 | 4.62 | 0.00 |
Surrozen | SRZN | Nov 4, 2024 | 11.88 | -10.20 |
Sutro Biopharma | STRO | Nov 4, 2024 | 3.69 | +3.94 |
Suzano ADR | SUZ | Nov 4, 2024 | 10.34 | +1.17 |
Sweden Index MSCI Ishares | EWD | Nov 4, 2024 | 39.99 | +0.20 |
Sweetgreen | SG | Nov 4, 2024 | 38.05 | +0.08 |
Swiftmerge Acquisition A | IVCP | Nov 4, 2024 | 11.06 | 0.00 |
Swiftmerge Acquisition Unit | IVCPU | Nov 4, 2024 | 11.30 | 0.00 |
Swiss Franc Trust | FXF | Nov 4, 2024 | 102.83 | +0.74 |
Swiss Helvetia Fund | SWZ | Nov 4, 2024 | 8.21 | +0.12 |
Switzerland Alphadex First Trust | FSZ | Nov 4, 2024 | 66.96 | -0.21 |
Switzerland Index MSCI Ishares | EWL | Nov 4, 2024 | 49.74 | +0.14 |
SWK Holdings | SWKH | Nov 4, 2024 | 16.58 | +0.36 |
Swvl Holdings A | SWVL | Nov 4, 2024 | 3.46 | +5.49 |
SYLA Technologies Co., Ltd. - American Depositary Shares | SYT | Nov 4, 2024 | 1.49 | -1.65 |
Sylvamo | SLVM | Nov 4, 2024 | 85.35 | +0.41 |
Symbotic | SYM | Nov 4, 2024 | 28.53 | +0.32 |
Synaptics | SYNA | Nov 4, 2024 | 69.27 | -1.35 |
Synaptogenix | SNPX | Nov 4, 2024 | 2.85 | -3.72 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.